| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000053167A3 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 02/15/2001 | WO2000051571A3 Capsule system |
| 02/15/2001 | WO1999066902A8 Injectable pharmaceutical formulations of partricin derivatives |
| 02/15/2001 | DE19960167A1 Verfahren zur Herstellung pulverförmiger partikelreduzierter Formulierungen mit Hilfe verdichteter Gase A process for preparing powdered particles reduced formulations using compressed gases |
| 02/15/2001 | DE19938098A1 Production of solid thioctic acid formulations comprises dry granulation or direct tabletting of active agent with adjuvants |
| 02/15/2001 | DE19936672A1 Reinforcing epithelial barrier of vaginal mucosa for prophylaxis of perinatally, sexually or other vaginally transferred infections comprises topical application of retinoic acid or its ester or retinol ester |
| 02/15/2001 | CA2403910A1 Headache and colic relief composition with asafetida and method of use thereof |
| 02/15/2001 | CA2381224A1 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 02/15/2001 | CA2381042A1 Block copolymers having a polymer segment derived from oxazoline |
| 02/15/2001 | CA2380312A1 Formulations for parenteral use of estramustine phosphate and albumin |
| 02/15/2001 | CA2378591A1 Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same |
| 02/15/2001 | CA2378578A1 Means for creating a mass having structural integrity |
| 02/15/2001 | CA2378572A1 Intravaginal clindamycin ovule composition |
| 02/15/2001 | CA2378486A1 Osteogenesis promoter sustained-release paste |
| 02/15/2001 | CA2378468A1 Hydrodynamically balancing oral drug delivery system |
| 02/15/2001 | CA2378445A1 Use of anti-muscarinic agents for treating skin disorders |
| 02/15/2001 | CA2378401A1 Implantable active ingredient depot |
| 02/15/2001 | CA2378267A1 Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof |
| 02/15/2001 | CA2378257A1 Method for increasing optic nerve, choroidal and retinal blood flow to facilitate the preservation of sight |
| 02/15/2001 | CA2377422A1 Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof |
| 02/15/2001 | CA2348959A1 Methods of cytoprotection using an enantiomer of estrogen of ischemic damage |
| 02/14/2001 | EP1075839A1 Plasma expander, blood diluent and cryoprotector produced using amylopectin-potato starch |
| 02/14/2001 | EP1075838A2 Powder coating method and composition for electrostatic coating of pharmceutical substrates |
| 02/14/2001 | EP1075837A2 Process for the preparation of aqueous formulations for ophthalmic use |
| 02/14/2001 | EP1075836A2 Skin care of food composition containing N-acetyl-glucosamine |
| 02/14/2001 | EP1075830A1 Procedure for the production of capsules and tablets of natural substances of vegetable origin |
| 02/14/2001 | EP1075489A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
| 02/14/2001 | EP1075461A2 Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 02/14/2001 | EP1075276A2 Adjuvant composition and methods for its use |
| 02/14/2001 | EP1075265A1 Use of tetracyclines for treating meibomian gland disease |
| 02/14/2001 | EP1075263A1 Aqueous process for manufacturing paroxetine solid dispersions |
| 02/14/2001 | EP1075256A1 Arylhydrocarbon receptor ligand antagonists |
| 02/14/2001 | EP1075253A2 Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use |
| 02/14/2001 | EP1075252A2 Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
| 02/14/2001 | EP1075251A2 Therapeutic system for applying at least one care or active agent topically or transmucosally, on or through the nasal mucosa, and method for using the system |
| 02/14/2001 | EP0929229B1 Chewing gum with sweetening agent |
| 02/14/2001 | CN1283997A Keratinocyte growth factor-2 formulations |
| 02/14/2001 | CN1283993A Method for producing solid dosing forms |
| 02/14/2001 | CN1283992A Sustained release drug delivery device |
| 02/14/2001 | CN1283991A Soft-pellet drug and process for prepn, thereof |
| 02/14/2001 | CN1283990A Long cating injectable formulations contg. hydrogenated castor oil |
| 02/14/2001 | CN1283989A Micropartical inhalation formulations |
| 02/14/2001 | CN1283983A Improved personal formulations |
| 02/14/2001 | CN1283505A Prescription and process for preparing medicine to treat toothche and odontopathy |
| 02/14/2001 | CN1283501A Spary for treating laryngitis and its preparing process |
| 02/14/2001 | CN1283500A Freeze-dried 'Shenmai' powder for injection and its preparing process |
| 02/14/2001 | CN1283499A Aseptic 'Shenmai' powder for injection and its preparing process |
| 02/14/2001 | CN1283494A Chinese-medicinal oral liquid containing only single active component |
| 02/14/2001 | CN1283489A Picking for giving out smoking and its preparing process |
| 02/14/2001 | CN1283487A Buccal kawa lozenge and its preparing process |
| 02/14/2001 | CN1283481A Process for preparing liquid medicine to cure verrucosis and gonorrhea |
| 02/14/2001 | CN1283476A 'Qingzhang Hingmu' pills for clearing eyes |
| 02/14/2001 | CN1283463A Process for preparing solid-state-microspherical vascular suppository of sodium alginate |
| 02/14/2001 | CN1283454A Method for preparing pellet contg fat-soluble substances |
| 02/14/2001 | CN1283453A Suppository for treating cold |
| 02/14/2001 | CN1283413A Skin-care agent, health and face-care foodstuff |
| 02/14/2001 | CN1061891C External-use ointment for chronic bronchitis and pulmonary emphysema |
| 02/14/2001 | CN1061888C Method for preparing red medicine for treating ulcer |
| 02/14/2001 | CN1061882C Chinese medicine for treating apoplexy |
| 02/14/2001 | CN1061874C Vision recovering capsule and its preparing method |
| 02/14/2001 | CN1061873C Process for preparing cold defervescent powder by using flocculating method |
| 02/14/2001 | CN1061872C Synergy liquid of compound salvia |
| 02/14/2001 | CN1061857C Powder for curing toothache |
| 02/14/2001 | CN1061856C External-use preparation for treating sterility |
| 02/14/2001 | CN1061848C Injection for curing cystic and its prepn tech |
| 02/14/2001 | CN1061844C External-use antithyroid cream |
| 02/13/2001 | USRE37053 Particles incorporating surfactants for pulmonary drug delivery |
| 02/13/2001 | US6187818 Prostaglandins formulation and process |
| 02/13/2001 | US6187803 Treating allergic disease, autoimmune disease, immunodeficiency syndrome, inflammatory disease or eosinophilia by orally administering a histamine-added immunoglobulin and carrier; tablets, capsules |
| 02/13/2001 | US6187765 Mometasone furoate suspensions for nebulization |
| 02/13/2001 | US6187763 Containing petrolatum solid oil, squalane liquid oil, ionic polysaccharide and nonionic surfactant |
| 02/13/2001 | US6187760 Cationic phospholipids for transfection |
| 02/13/2001 | US6187747 Hydrophilic carrier medium comprising propylene glycol, esters of propylene glycol and polyoxyethylene hydrogenated castor oils |
| 02/13/2001 | US6187586 Nucleotide sequence of compound which inhibits expression of human serine/threonine kinase involved in signal transduction; diagnosis, prophylaxis, and therapy of related diseases |
| 02/13/2001 | US6187368 Microparticle emulsions of albumin, carbohydrates and phospholipids |
| 02/13/2001 | US6187351 Encapsulation compositions |
| 02/13/2001 | US6187346 Intrauterine chemical cauterizing method and composition |
| 02/13/2001 | US6187345 Flutamide compositions and preparations |
| 02/13/2001 | US6187344 Powdered pharmaceutical formulations having improved dispersibility |
| 02/13/2001 | US6187343 Multistage mixing, micronization, rotation and separation |
| 02/13/2001 | US6187342 Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt |
| 02/13/2001 | US6187341 Trovafloxacin mesylate tablet |
| 02/13/2001 | US6187340 Stabilized pharmaceutical preparation |
| 02/13/2001 | US6187339 Solid pharmaceutical composition comprising an excipient capable of binding water |
| 02/13/2001 | US6187338 Anticonvulsants and analgesics |
| 02/13/2001 | US6187337 Rapidly dissolving dosage form |
| 02/13/2001 | US6187336 Process for producing a solid which is rapidly soluble in the oral cavity |
| 02/13/2001 | US6187335 Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom |
| 02/13/2001 | US6187332 Killing rhinovirus in human nose |
| 02/13/2001 | US6187331 Composition for prophylaxis and/or treatment of dry syndrome comprising vitamin D |
| 02/13/2001 | US6187330 Local delivery of angiogenic amounts of basic fibroblast growth factor or vascular endothelial growth factor. |
| 02/13/2001 | US6187327 Contains 2,4,4'-trichloro-2'-hydroxydiphenyl ether as the antimicrobial agent |
| 02/13/2001 | US6187323 The use of this composition as a reservoir of active ingredients in a transdermal release system. |
| 02/13/2001 | US6187322 Process and a device for the production of a flat administration form comprising a preparation which contains pharmaceutical active substances |
| 02/13/2001 | US6187290 Foamable carrier and an active ingredient; especially useful for medical applications, for example in treating burns. |
| 02/13/2001 | US6187288 Stable microbubble suspensions as enhancement agents for ultrasonic echography |
| 02/13/2001 | US6186148 Prevention of posterior capsular opacification |
| 02/13/2001 | CA2280316A1 Transdermal, oral and intravenous formulations of 2,3-dimethoxy-5-methyl-6-dacaprenyl-1,4-benzoquinone |
| 02/13/2001 | CA2192674C Methods for treating respiratory disease |